RE:RE:RE:Companies now seek to moderate TME to expand PD-(L)1 effect
Yes. You are right.
Just for fun (and sometimes just searching words brings some clarity) I searched: PDAC CD8 GOBLET and pelareorep. The results were interesting. No question Roche placed this trial in very good hands indeed.
I am still debating whether or not to add a few shares (my position is small beer compared to most) and I must be careful.
As someone said the other day pela looks to be versatile. Very versatile.
In the final analysis it is simly a guess as to when to buy, and I am undecided, but do admit GOBLET may have gem-like quality.
Decisions. Decisions!